BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 25348311)

  • 1. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
    Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
    Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
    Le L; Luo J; Wu H; Chen L; Tang X; Fu F
    Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.
    Clarke M; Dumon S; Ward C; Jäger R; Freeman S; Dawood B; Sheriff L; Lorvellec M; Kralovics R; Frampton J; García P
    Leukemia; 2013 Mar; 27(3):661-70. PubMed ID: 22910183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
    Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
    Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction.
    Rafatian G; Kamkar M; Parent S; Michie C; Risha Y; Molgat ASD; Seymour R; Suuronen EJ; Davis DR
    Aging Cell; 2020 Jul; 19(7):e13174. PubMed ID: 32558221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell survival pathways of the primordial RNA-DNA complex remain conserved in the extant genomes and may function as proto-oncogenes.
    Sinkovics JG
    Eur J Microbiol Immunol (Bp); 2015 Mar; 5(1):25-43. PubMed ID: 25883792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYBL2 (B-MYB) in cervical cancer: putative biomarker.
    Astbury K; McEvoy L; Brian H; Spillane C; Sheils O; Martin C; O'Leary JJ
    Int J Gynecol Cancer; 2011 Feb; 21(2):206-12. PubMed ID: 21270603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
    Brake T; Connor JP; Petereit DG; Lambert PF
    Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
    Samir R; Asplund A; Tot T; Pekar G; Hellberg D
    J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
    Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
    Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.
    Bayley R; Ward C; Garcia P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188407. PubMed ID: 32853735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of MYBL2 as a novel candidate biomarker of cervical cancer.
    Martin CM; Astbury K; Kehoe L; O'Crowley JB; O'Toole S; O'Leary JJ
    Methods Mol Biol; 2015; 1249():241-51. PubMed ID: 25348311
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.